Tour de France: CAS issues judgement in the Quintana case

The disqualification of the Colombian at this year's Tour de France remains in place. The International Court of Arbitration for Sport (CAS) rejected the climbing specialist's appeal on Thursday. As a result, Quintana loses his sixth place overall.

Tramadol detected in Quintana

In two dried blood samples taken from the 32-year-old on 8 and 13 July the opiate tramadol was detected. According to the UCI, this is not a doping offence, but a violation of the federation's medical rules. Tramadol has been banned by the UCI since 1 March due to its side effects, but is not on the World Anti-Doping Agency Wada's list of banned substances. As part of a programme to detect tramadol, 120 so-called dried blood samples were taken during the Tour.

• All transfers of the top teams for the 2023 season

Quintana has now also announced his departure from the French team Arkea-Samsic. It is not yet known whether and where the two-time Tour runner-up will continue to ride. The offence did not result in a ban.

Copyright 2022, dpa (www.dpa.de). All rights reserved